Ballad Ventures

What Ballad Ventures does

Ballad Ventures is the corporate venture capital arm of Ballad Health, an integrated 21-hospital community health system headquartered in Johnson City, Tennessee, founded in 2020 and operating with a two-person leadership team (Managing Director Mike Anderes and President Bo Wilkes). The fund invests in early-stage healthcare technology companies from Pre-Seed through Series B, with initial checks up to $1.5 million, targeting Digital Health, Medtech, Tech-enabled Services, Consumer Health and Wellness, and Health Care Operational Infrastructure. Its current portfolio of seven companies — Tessellate (physician career matching), 410 Medical (rapid fluid resuscitation device), EvidenceCare (EHR-integrated clinical decision support), Homecare Hub (shared care homes), Censinet (healthcare cyber and vendor risk), TailorMed (patient financial navigation), and Winter Innovations (orthopedic suturing tools) — reflects a thesis built around deploying vendor innovation inside the parent health system's clinical operations.

The fund's competitive position rests on three reinforcing assets: a captive clinical distribution channel (the 21-hospital network spanning 29 counties across the Appalachian Highlands), a leadership team with national-scale digital health and venture experience (Anderes previously led a $50M corporate venture fund at Froedtert Health and co-founded the Vale Health consortium), and an LP backstop in the form of Ballad Health's balance sheet, which removes the fundraising frictions typical of sub-$50M emerging managers. The fund sources deals through inbound founder applications, LinkedIn presence, and a content-marketing thought leadership platform focused on rural and community health innovation.

The business model is a corporate venture structure: capital is supplied by the parent system, returns are generated through equity appreciation, exits, and portfolio company growth, and operational value-add is delivered via clinical pilot pathways and innovation-center resources housed inside Ballad Health. As a wholly-owned subsidiary with no publicly disclosed fund size, AUM, or revenue, Ballad Ventures' financial profile is opaque, and its economic fortunes are tightly coupled to Ballad Health's strategic priorities. The fund does not build or sell technology products; its 'product' is capital plus clinical distribution plus strategic guidance to portfolio founders.

Name

Ballad Ventures

Legal name

Ballad Ventures

Website

https://balladventures.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Ballad Ventures is the corporate venture capital arm of Ballad Health, a 21-hospital Appalachian health system, investing up to $1.5 million in Pre-Seed through Series B healthcare technology companies with deployment pathways into the parent's clinical network.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

SDG / Thematic Sustainable Investment Funds (FSANAJAN)

Keywords

• Healthcare venture capital
• Early-stage investing
• Corporate venture capital
• Health technology investment
• Medical innovation funding

Headquarters

HQ city

Johnson City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Investment Returns: Ballad Ventures generates returns through equity investments in early-stage healthcare technology companies. As an investment arm of Ballad Health, they invest in startups that align with their mission to transform healthcare delivery, seeking returns through portfolio company growth, acquisitions, and exits.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Ballad Ventures is the investment arm of Ballad Health, operating as a corporate venture capital fund that invests in early-stage healthcare technology companies (Pre-Seed through Series B) with initial checks up to $1.5 million. It provides both financial capital and deep operational support drawn from Ballad Health's 21-hospital integrated healthcare network, helping portfolio companies move from early prototype to scale across digital health, medtech, tech-enabled services, consumer health and wellness, and healthcare operational infrastructure.

Product overview

Ballad Ventures is an investment arm of Ballad Health, functioning as a healthcare venture capital fund. It is not a software product company. The entity's offerings consist of investment services, partnership opportunities, and operational support for early-stage healthcare technology companies. Its portfolio includes seven healthcare technology companies (Tessellate, 410 Medical, EvidenceCare, Homecare Hub, Censinet, TailorMed, and Winter Innovations), but these are portfolio companies in which Ballad Ventures has invested—not products or services offered directly by Ballad Ventures.

Differentiator

Problem solved

Functional benefit

Products and services

• Equity Investment and Operational Support Equity investment program providing Pre-Seed through Series B funding up to $1.5 million per portfolio company, paired with deep operational support drawn from Ballad Health's 21-hospital integrated healthcare network. Targeted at early-stage healthcare technology companies developing solutions in digital health, medtech, tech-enabled services, consumer health and wellness, and healthcare operational infrastructure.
• Startup Assessment Intake Online "Tell Us About Yourself" assessment form hosted on the Ballad Ventures website through which early-stage healthcare founders can submit their company and idea for potential investment consideration.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• Emplify HealthminorStrategic or Co-development PartnerEmplify Health partnered with Homecare Hub (a Ballad Ventures portfolio company) to address critical post-hospital care gaps. This partnership demonstrates portfolio companies' ability to form strategic relationships within the healthcare ecosystem.
• Flatiron HealthminorStrategic or Co-development PartnerTailorMed (a Ballad Ventures portfolio company) partnered with Flatiron Health to expand medication access and support across oncology care. This partnership shows portfolio companies' ability to secure strategic partnerships.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Optum Ventures: The corporate venture capital arm of Optum/UnitedHealth Group, investing in early- and growth-stage healthcare technology companies with a focus on deployment across a large payer-provider ecosystem — the most direct comparison to Ballad Ventures as a health-system-aligned CVC.
• Ascension Ventures: Corporate venture capital arm of Ascension Health, investing across digital health, medical devices and healthcare services with health-system distribution advantages — a comparable Catholic-system CVC model to Ballad Ventures.
• OSF Ventures: The investment arm of OSF HealthCare, a Catholic integrated health system investing in digital health, medtech and care delivery — a closely comparable rural/health-system CVC with similar check-size and operational-support model.
• LRVHealth: Early-stage venture firm investing exclusively in healthcare innovation across digital health, tech-enabled services and healthcare IT — comparable as a healthcare-focused, network-driven investor that wraps operational support around checks.
• Mayo Clinic Ventures: The technology transfer, commercialization and investment arm of Mayo Clinic — a provider-affiliated platform that invests in and spins out healthcare technologies using clinical expertise as a competitive moat, conceptually similar to Ballad Ventures.
• Kaiser Permanente Ventures: Corporate venture arm of Kaiser Permanente investing in healthcare technology aligned with the integrated health-system model — directly comparable in using a large provider network as both strategic filter and distribution channel.
• Echo Health Ventures: Strategic healthcare investment platform formed by Cambia Health Solutions and Mosaic Health Solutions, investing across payer, provider and digital health — a like-sized, mission-aligned healthcare CVC comparable to Ballad Ventures.
• UPMC Enterprises: The venture and commercialization arm of UPMC, investing in and building healthcare technology companies that can be deployed across a major integrated delivery network — the same playbook Ballad Ventures pursues inside Ballad Health.

Broad incumbents

• Andreessen Horowitz (a16z Bio/Health): Large venture firm with a dedicated bio/health fund investing across healthcare and life sciences at scale. Not a direct competitor on check size, but a dominant incumbent whose deal activity defines the competitive landscape Ballad Ventures operates in.
• General Catalyst: Large global venture firm with a deep healthcare practice (Health Assurance) backing early- and growth-stage health tech, often co-investing with health systems. Sets the bar for what Ballad Ventures' portfolio CEOs benchmark against.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/ballad-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ballad Ventures